financetom
Business
financetom
/
Business
/
Calvin Klein Parent PVH's Stock Falls After Q2 Results: Sees Q3 Revenue Decline, Guides Q3 EPS Below Estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Calvin Klein Parent PVH's Stock Falls After Q2 Results: Sees Q3 Revenue Decline, Guides Q3 EPS Below Estimates
Aug 28, 2024 3:10 AM

PVH Corp. ( PVH ) shares are trading lower after reporting its second-quarter financial results, guided a third-quarter revenue decline and issued earnings guidance below estimates after Tuesday's closing bell. Here's a look at the key figures from the report. 

The Details: PVH reported quarterly earnings of $3.01 per share, which beat the analyst consensus estimate of $2.29 by 31.44%. Quarterly sales came in at $2.074 billion which beat the analyst consensus estimate and is a 6.03% decrease from the same period last year.

Revenue in the company’s international businesses decreased by 4% compared to the prior year period, primarily due to the challenging consumer environment in Asia Pacific, particularly in China and Australia, and the continuation of planned strategic reduction in sales in Europe to drive overall higher quality of sales in the region.

In North America, revenue in the Tommy Hilfiger and Calvin Klein businesses combined increased by 1% compared to the prior year period, with modest growth in the wholesale business and a low single-digit decline in the direct-to-consumer business.

Direct-to-consumer revenue decreased 5% compared to the prior year period.

Revenue in the company’s owned and operated stores decreased by 4% compared to the prior year period, primarily driven by recent softness in the consumer backdrop.

Revenue in the company’s owned and operated digital commerce business declined 6% compared to the prior year period, primarily due to the continuation of the company’s planned strategic reduction in Europe.

Read Next: Apple Announces CFO Transition, iPhone 16 Debut: What To Know

“We delivered on our top- and bottom-line commitments and beat our earnings guidance for the second quarter, led by our disciplined execution of the PVH+ Plan,” commented Stefan Larsson, CEO of PVH.

“For both Calvin Klein and Tommy Hilfiger, we drove strong consumer engagement and continued to increase product strength and improve newness in our assortment, leading to more full-priced selling and less end-of-season clearance sales, which fueled significant gross margin expansion.”

Outlook: PVH expects third-quarter revenue to decrease by 6% to 7% and sees earnings of approximately $2.50 per share versus the $3.12 estimate. The company reaffirmed the fiscal year 2024 revenue decrease of 6% to 7% and raised its earnings outlook from between $11.00 and $11.25 per share to between $11.55 and $11.80 per share versus the estimate of $11.31.

PVH Price Action: According to Benzinga Pro, PVH shares are down 7.29% after-hours at $96.85 at the time of publication Tuesday.

Read Also:

What’s Going On With EV-Maker Rivian’s Stock?

Image: Shutterstock

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Explainer-Trump's Mexico tariff threats: what has been said and what would the impact be?
Explainer-Trump's Mexico tariff threats: what has been said and what would the impact be?
Jan 31, 2025
MEXICO CITY (Reuters) - If U.S. President Donald Trump follows through on his pledge to slap 25% tariffs on imports from Mexico it could usher in a volatile new chapter in the longstanding trade relationship with the impacts hitting consumers. Mexico is the United States' largest trading partner, representing over 15% of total trade. The U.S. imported more than $475...
Biogen, Eisai Say EU Panel Set to Discuss Additional Safety Data on Lecanemab
Biogen, Eisai Say EU Panel Set to Discuss Additional Safety Data on Lecanemab
Jan 31, 2025
08:09 AM EST, 01/31/2025 (MT Newswires) -- Biogen (BIIB) and Eisai said Friday that the European Medicines Agency's Committee for Medicinal Products for Human Use is expected to discuss in February additional safety data on lecanemab as treatment for early Alzheimer's disease. The committee recommended the approval of lecanemab in November 2024, but was asked by the European Commission to...
Canadian bitcoin miner Bitfarms mulls pivot to AI data centers
Canadian bitcoin miner Bitfarms mulls pivot to AI data centers
Jan 31, 2025
(Reuters) - Toronto-based bitcoin miner Bitfarms ( BITF ) has enlisted two consultants to explore how it can transform some of its facilities to meet the growing demand for artificial intelligence data centers, it said on Friday. WHY IT'S IMPORTANT Crypto miners often own large plots of land and significant power resources - assets that are also crucial for high-performance...
Vestis Names New Chief Financial Officer, Chief Legal Officer
Vestis Names New Chief Financial Officer, Chief Legal Officer
Jan 31, 2025
08:08 AM EST, 01/31/2025 (MT Newswires) -- Vestis ( VSTS ) said Friday it has named Kelly Janzen its chief financial officer, starting Feb. 14. Janzen, who has worked with Vestis ( VSTS ) as a finance consultant since October 2024, previously had served as finance executive in residence at Fernweh Group and CFO for Dabico Airport Solutions from January...
Copyright 2023-2026 - www.financetom.com All Rights Reserved